Researchers track steroid's journey from mom to baby to fight newborn breathing crisis
NCT ID NCT01854840
Summary
This study aimed to understand how a steroid drug called betamethasone, given to pregnant women at risk of early delivery, passes through the placenta to the baby. Researchers followed 127 women to measure drug levels in mother and baby and see how this transfer relates to the severity of a serious newborn lung condition called Hyaline Membrane Disease. The goal was to gather knowledge to help optimize future dosing for better prevention.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PREGNANT WOMEN RECEIVE CELESTEN are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Necker Hospital
Paris, 75015, France
Conditions
Explore the condition pages connected to this study.